Filing Details
- Accession Number:
- 0001225208-24-005743
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-07 17:53:27
- Reporting Period:
- 2024-05-03
- Accepted Time:
- 2024-05-07 17:53:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1099800 | Edwards Lifesciences Corp | EW | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 364316614 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1665141 | J Bernard Zovighian | One Edwards Way Irvine CA 92614 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-05-03 | 527 | $85.06 | 44,289 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2024-05-04 | 6,265 | $0.00 | 50,554 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-05-04 | 3,718 | $85.25 | 46,836 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2024-05-06 | 580 | $85.74 | 3,268 | No | 4 | P | Indirect | 401(k) |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | P | Indirect | 401(k) |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Rights | Disposition | 2024-05-04 | 6,265 | $0.00 | 6,265 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-05-04 | No | 4 | M | Direct |
Footnotes
- On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4.
- Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.
Billionaire Hedge Funds
